Xerostomia. Etiologia e Tratamento

Brennan, 2002, Treatment of xerostomia: a systemic review of therapeutic trials, The Dental Clinics of North America, 46, 847, 10.1016/S0011-8532(02)00023-X Guggenheimer, 2003, Xerostomia: etiology, recognition and treatment, JADA, 134, 61 Ghezzi, 2000, Determination of variation of stimulated salivary flow rates, J Dent Res, 79, 1874, 10.1177/00220345000790111001 Baum, 1981, Evaluation of stimulated parotid saliva flow rate in different age groups, J Dent Res, 60, 1292, 10.1177/00220345810600070101 Navazesh, 1996, Relationship of medical status, medication, and salivary flow rates in adults of diferents ages, Oral Surg Oral Med Oral Pathol Oral Endod, 81, 172, 10.1016/S1079-2104(96)80410-0 Narhi, 1994, Prevalence of subjective feelings of dry mouth in the elderly, J Dent Res, 73, 20, 10.1177/00220345940730010301 Screebny, 1997, 14 Ship, 1991, How to mutch saliva is enough to normal function defined, JADA, 122, 63 Fox, 1985, Xerostomia: evaluation of a symptom with increasing significance, J Am Dent Assoc, 110, 519, 10.14219/jada.archive.1985.0384 Vicent, 2008, Minor salivary gland tumors: A clinicopathological study of 18 cases, Med Oral Patol Oral Cir Bucal, 13, 582 Christensen, 2000, Film-forming properties and viscosities of saliva substitutes and human whole saliva, European Journal of Sciences, 108, 418, 10.1034/j.1600-0722.2000.108005418.x Meyer, 2002, The effect of commercially available saliva substituts on predmineralized bovine dentin in vitro, Oral Diseases, 8, 192, 10.1034/j.1601-0825.2002.01762.x Rode, 1999, Gaspusic d. the effect of pilocarpine and biperidine on salivary secretion during and after radiotherapy in head and neck cancer patients, Int. J. Radiation Oncology Biol. Phys, 45, 337, 10.1016/S0360-3016(99)00165-0 Shiboski, 2007, Management of salivary hypofunction during and after radiotherapy, Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod, 103 Atkinson, 1994, Salivary gland dysfunction: causes, symptoms and treatment, J Am Dent Assoc, 125, 409, 10.14219/jada.archive.1994.0059 Sciubba, 2006, Oral complications of radiotherapy, Lancet Oncol, 7, 175, 10.1016/S1470-2045(06)70580-0 Amerongen, 2003, Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies, Support Care Cancer, 11, 226, 10.1007/s00520-002-0409-5 Shiboski, 2007, Management of salivary hypofunction during and after radiotherapy, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics, 103 Cassolato, 2003, Xerostomia: clinical aspects and treatment, Gerodontology, 20, 7789, 10.1111/j.1741-2358.2003.00064.x Rubira, 2007, Evaluation of same oral postradiotherapy sequelae in patients treated for head and neck tumors, Braz Oral Res, 21, 272, 10.1590/S1806-83242007000300014 Pjipe, 2007, Progression of salivary gland dysfunction in patients with Sjögren Syndrome, Annals of the Rheumatic Disease Philip, 2004, Salivary Enhancement Therapies, Caries Res, 38, 241, 10.1159/000077761 Sotto-Rojas, 2002, The oral Side of Sjögren syndrome. Diagnosis and treatment. A review, Archives of Medical Research, 33, 95, 10.1016/S0188-4409(01)00371-X Dawson, 2005, Hydroxichloroquine therapy in patients with primary Sjogrens syndrome may improve salivary gland hypofunction of glandular cholinesterase, Rheumatology, 44, 449, 10.1093/rheumatology/keh506 Rhodus, 1999, Sjogren syndrome Quintissence International, 30, 689